How should we address the inevitable harms from non‐negligent variant reclassification in predictive genetic testing?
Journal of Genetic Counseling · 2023-02 · 32 (1) · 18-30
DOI: 10.1002/jgc4.1638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 19.10.2022. Verfasst von Misha Rashkin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Health Care, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Genetic Variation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The process of interpreting genetic variants, in which experts use all available evidence to determine whether an identified variant is associated with a current or future disease, is both scientific and nevertheless subjective. In this paper, we summarize the existing evidence that any given variant could be reclassified and that such a reclassification could lead to harm. Furthermore, the racial gap in genetic databases could lead to a higher likelihood of harm for non‐white patients. We also review recent legal analyses indicating it is unlikely that an individual who sues for restitution would be successful, especially in the absence of evidence of lab negligence. We then propose a compensation program for medical genetic tests to ensure that individuals who experience demonstrable harm due to a variant reclassification can be made whole financially. We conclude by discussing outstanding questions that must be answered for such a program to be feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford Health Care, Palo Alto, California, USA.
- Sarah Lawrence College, Bronxville, New York, USA.
- Genetic Counseling Graduate Program, Stanford University, Stanford, California, USA.
- The University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Misha Rashkin
Zitieren
APA
Rashkin, M., Kingham, K., Lara-Otero, K., Mckenna, M., Villiers, J., Worthington, M. M., & Prince, A. (2023). How should we address the inevitable harms from non‐negligent variant reclassification in predictive genetic testing?. Journal of Genetic Counseling, 32(1), 18-30. https://doi.org/10.1002/jgc4.1638
Vancouver
Rashkin M, Kingham K, Lara-Otero K, Mckenna M, Villiers J, Worthington MM, et al. How should we address the inevitable harms from non‐negligent variant reclassification in predictive genetic testing?. Journal of Genetic Counseling. 2023;32(1):18-30. doi:10.1002/jgc4.1638
BibTeX
@article{Rashkin2023,
author = {Rashkin, Misha and Kingham, Kerry and Lara-Otero, Karlena and Mckenna, Meghan and Villiers, Janelle and Worthington, Monty Mykolas and Prince, Anya},
title = {How should we address the inevitable harms from non‐negligent variant reclassification in predictive genetic testing?},
journal = {Journal of Genetic Counseling},
year = {2023},
volume = {32},
number = {1},
pages = {18--30},
doi = {10.1002/jgc4.1638}
}
EUVIMED